Gilde Healthcare strengthens Investor Relations and Fundraising team with Besmire Ahmati - Gilde Healthcare

Gilde Healthcare strengthens Investor Relations and Fundraising team with Besmire Ahmati

June 9, 2023
Utrecht (The Netherlands)

Gilde Healthcare, a leading transatlantic investment firm specialized in the healthcare sector, is pleased to announce the addition of Besmire Ahmati to its team as Associate Investor Relations and Fundraising.

In this new role, Besmire will focus on supporting Gilde Healthcare’s investor relations activities and contribute to the firm’s capital raising and communications efforts. With over 5 years of experience in financial services and more recently as an LP investor, Besmire brings valuable expertise to Gilde Healthcare.

“We are pleased to welcome Besmire to our Investor Relations and Fundraising team,” said Pieter van der Meer, Managing Partner of Gilde Healthcare. “Her experience with institutional investors such as PGGM and FMO, strong industry relationships, and entrepreneurial mindset will help in building out our fundraising strategy and investor relationships.”

Prior to joining Gilde Healthcare, Besmire was part of the PGGM Private Equity team as a Junior Investment Manager investing in a global portfolio of private equity funds and co-investments. Prior to that, Besmire worked as a portfolio analyst in distressed assets transactions in private markets for FMO – the Dutch Entrepreneurial Development Bank. She began her career at Van Lanschot Kempen as an investment graduate.

“I am honored to be a part of Gilde Healthcare’s exceptional team and contribute to the firm’s continued success. I look forward to collaborating with our existing and prospective investors, delivering exceptional service, and fostering long-term partnerships with our stakeholders.” said Ahmati.

About Gilde Healthcare
Gilde Healthcare is a specialized healthcare investor managing over €2.5 billion across two fund strategies: Venture&Growth and Private Equity. The Venture&Growth fund of Gilde Healthcare invests in fast growing companies active in digital health, medtech and therapeutics, based in Europe and North America. The Private Equity fund of Gilde Healthcare participates in profitable lower mid-market healthcare companies based in North-Western Europe. For more information, visit the company’s website at www.gildehealthcare.com.

Gilde Healthcare company CatalYm announces leadership changes to accelerate visugromab late-stage clinical development

Gilde Healthcare company CatalYm, a world-leader in neutralizing GDF-15 in cancer and cachexia, today announced changes to its executive leadership team to support its next stage of growth. The appointments of Clinton Musil as Chief...
September 15, 2025

Gilde Healthcare company Tagworks Pharmaceuticals Announces Initiation of Third Dose Level in Ongoing Phase 1 Clinical Trial of TGW101 for the Treatment of Solid Tumors

TGW101 is a next-generation, first-in-class ADC targeting TAG-72 with an MMAE payload, developed based on Tagworks proprietary Click-to-Release linker chemistry; TGW101 is the first bioorthogonal, in vivo click chemistry-activated ADC, which enables superior control of tumor...
September 10, 2025

Gilde Healthcare appoints Dr. Christian Stark as Group CEO of its globally operating medical technology group

The medical technology group, which includes two manufacturers of surgical instruments in the Tuttlingen region, Koscher & Würtz and Christian Diener, has appointed Dr. Christian Stark as Chief Executive Officer (CEO) with effect from September...
September 3, 2025